Safety and preliminary efficacy of JK500 cell injection in relapsed/refractory pediatric acute myeloid leukemia
开始日期2022-10-01
申办/合作机构-
NCT05519384
/ Recruiting早期临床1期IIT
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
This study is a prospective, single-center, single-arm exploratory clinical study, aiming to complete the preliminary clinical observation of 12 children with relapsed/refractory acute myeloid leukemia treated with JK500 cell injection to evaluate the safety of clinical infusion and the initial efficacy of JK500 cell injection in the treatment of children with relapsed/refractory acute myeloid leukemia.